Heterocyclic Compounds: Effective α-Amylase and α-Glucosidase Inhibitors

Author(s): Mina Saeedi, Abbas Hadjiakhondi, Seyed Mohammad Nabavi, Azadeh Manayi

Journal Name: Current Topics in Medicinal Chemistry

Volume 17 , Issue 4 , 2017

Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Diabetes Mellitus (DM) is a metabolic disease characterized by high blood sugar levels. Recently, it has emerged as an important and global health problem with long-term complications and high economic burden. α-Amylase (α-Amy) and α-glucosidase (α-Gls) are two enzymes which are involved in the hydrolysis of starch into sugars and disaccharides leading to the increase of blood glucose level. Hence, inhibition of α-amylase and α-glucosidase plays key role in the treatment of type 2 diabetes. Heterocyclic compounds -both synthetic and naturally occurring derivatives- possess efficient biological properties. At this juncture, they have demonstrated potent inhibitory activity against α-Amy and α-Gls and were found to be versatile tools for the development of novel anti-diabetic agents.

Keywords: α-Amylase, α-Glucosidase, Diabetes, Heterocycles, Synthesis, Natural Products.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2017
Page: [428 - 440]
Pages: 13
DOI: 10.2174/1568026616666160824104655
Price: $65

Article Metrics

PDF: 60